# A Study to Evaluate QTc Prolongation With Quizartinib in Healthy Subjects Under Rapid Acceleration of Heart Rate

> **NCT06772246** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 70 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Quizartinib
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06772246
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-24
- **Primary completion:** 2025-06-12
- **Final completion:** 2025-06-12
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06772246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06772246, "A Study to Evaluate QTc Prolongation With Quizartinib in Healthy Subjects Under Rapid Acceleration of Heart Rate". Retrieved via AI Analytics 2026-06-27 from https://api.ai-analytics.org/clinical/NCT06772246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*